SAR, a data analytics company specialized in the securities litigation risk of U.S. public companies, today published the Securities Class Action Rule 10b-5 Exposure Report for 4Q 2024. According to ...
According to the latest study from BCC Research, "Chronic Disease Management: Therapeutics, Device Technologies, and Global Markets," is projected to grow from $726.3 billion in 2024 to $1.1 trillion ...